Skip to main content
. 2022 Nov 9;23:69–79. doi: 10.1016/j.bioactmat.2022.09.027

Fig. 5.

Fig. 5

The dual-targeting effects of (pMETTL14+RS09)@cRGD-M. (A, C) pMETTL14 was labeled with FITC (green) and the membrane was labeled with DiD (red). Tumor cell-targeting ability of (pMETTL14+RS09)@M and (pMETTL14+RS09)@cRGD-M was investigated in vitro (scale bar: 20 μm; **p < 0.01). (B, D) The tumor accumulation ability of (pMETTL14+RS09)@cRGD-M was investigated in vivo (**p < 0.01). (E, F) Macrophage-targeting ability of (pMETTL14+RS09)@M and (pMETTL14+RS09)@cRGD-M was investigated in vitro (scale bar: 20 μm; n.s.: no significance).